Matthew W. Robertson

Phase II trial of ribociclib and letrozole in patients with relapsed oestrogen receptor-positive ovarian or endometrial cancers

J. Copland, N. Foster, S. Weroha, 2020, ESMO Open.

Phase 2 trial of everolimus and letrozole in relapsed estrogen receptor-positive high-grade ovarian cancers.

N. Foster, S. Weroha, P. Haluska, 2017, Gynecologic oncology.